Antiviral Activity of Ergoferon against Group A Rotavirus
- 作者: Emelianova A.1, Shilovskii I.2, Sundukova M.2, Khaitov M.2, Epshtein O.1
-
隶属关系:
- Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
- State Research Center Institute of Immunology, Federal Medical-Biological Agency
- 期: 卷 161, 编号 6 (2016)
- 页面: 806-807
- 栏目: Virology
- URL: https://journals.rcsi.science/0007-4888/article/view/237801
- DOI: https://doi.org/10.1007/s10517-016-3516-x
- ID: 237801
如何引用文章
详细
Antiviral activity of Ergoferon was studied in vitro on an experimental model of rotavirus infection in MA-104 cell line. In infected cells treated with Ergoferon, rotavirus titer was shown to decrease by 83 and 90% in comparison with cells treated with solvent used for Ergoferon preparation (p<0.05) and distilled water (p<0.05), respectively. These findings demonstrate high anti-rotavirus activity of Ergoferon.
作者简介
A. Emelianova
Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
编辑信件的主要联系方式.
Email: agemelianova@gmail.com
俄罗斯联邦, Moscow
I. Shilovskii
State Research Center Institute of Immunology, Federal Medical-Biological Agency
Email: agemelianova@gmail.com
俄罗斯联邦, Moscow
M. Sundukova
State Research Center Institute of Immunology, Federal Medical-Biological Agency
Email: agemelianova@gmail.com
俄罗斯联邦, Moscow
M. Khaitov
State Research Center Institute of Immunology, Federal Medical-Biological Agency
Email: agemelianova@gmail.com
俄罗斯联邦, Moscow
O. Epshtein
Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathology and Pathophysiology, Research Institute of General Pathology and Pathophysiology
Email: agemelianova@gmail.com
俄罗斯联邦, Moscow